OP  Patient Advocate (old timer, 2000 posts)
Joined: Dec 2003 Posts: 2,606 Likes: 2 | Paul, all MRI contrast using gadalinium were given an FDA Black Box Warning to screen for kidney issues before using. Gadavist was only approved in 2011 and is the 6th gadalinium contrast product and received a "less sever" risk of NFS (nephrogenic systemic fibrosis) on its Black Box Warning. NFS was only discovered around 1997 and although classified as a skin disorder, it can also include organs and muscles plus increase mucin production which would cause excess secretions, i.e. mucous.
The chelation process removes heavy metals and is believed, in theory, to remove residual radiation from the body although I don't believe it can be verified through testing.
Gadalinium based products are used for CNS scans.
SCC Stage IV, BOT, T2N2bM0
Cisplatin/5FU x 3, 40 days radiation
Diagnosis 07/21/03 tx completed 10/08/03
Post Radiation Lower Motor Neuron Syndrome 3/08.
Cervical Spinal Stenosis 01/11
Cervical Myelitis 09/12
Thoracic Paraplegia 10/12
Dysautonomia 11/12
Hospice care 09/12-01/13.
COPD 01/14
Intermittent CHF 6/15
Feeding tube NPO 03/16
VFI 12/2016
ORN 12/2017
Cardiac Event 06/2018
Bilateral VFI 01/2021
Thoracotomy Bilobectomy 01/2022
Bilateral VFI 05/2022
Total Laryngectomy 01/2023
| 
